Year |
Citation |
Score |
2023 |
Yang P, Li W, Fan X, Pan J, Mann CJ, Varnum H, Clark LE, Clark SA, Coscia A, Smith KN, Brusic V, Abraham J. Structural basis for VLDLR recognition by eastern equine encephalitis virus. Biorxiv : the Preprint Server For Biology. PMID 38014066 DOI: 10.1101/2023.11.14.567065 |
0.304 |
|
2022 |
Hale M, Netland J, Chen Y, Thouvenel CD, Smith KN, Rich LM, Vanderwall ER, Miranda MC, Eggenberger J, Hao L, Watson MJ, Mundorff CC, Rodda LB, King NP, Guttman M, ... ... Abraham J, et al. IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2. The Journal of Experimental Medicine. 219. PMID 35938988 DOI: 10.1084/jem.20220849 |
0.31 |
|
2022 |
Hickerson BT, Daniels-Wells TR, Payes C, Clark LE, Candelaria PV, Bailey KW, Sefing EJ, Zink S, Ziegenbein J, Abraham J, Helguera G, Penichet ML, Gowen BB. Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections. Nature Communications. 13: 558. PMID 35091550 DOI: 10.1038/s41467-021-27949-3 |
0.385 |
|
2021 |
Clark LE, Clark SA, Lin C, Liu J, Coscia A, Nabel KG, Yang P, Neel DV, Lee H, Brusic V, Stryapunina I, Plante KS, Ahmed AA, Catteruccia F, Young-Pearse TL, ... ... Abraham J, et al. VLDLR and ApoER2 are receptors for multiple alphaviruses. Nature. PMID 34929721 DOI: 10.1038/s41586-021-04326-0 |
0.304 |
|
2021 |
Nabel KG, Clark SA, Shankar S, Pan J, Clark LE, Yang P, Coscia A, McKay LGA, Varnum HH, Brusic V, Tolan NV, Zhou G, Desjardins M, Turbett SE, Kanjilal S, ... ... Abraham J, et al. Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. Science (New York, N.Y.). eabl6251. PMID 34855508 DOI: 10.1126/science.abl6251 |
0.309 |
|
2021 |
Wellner A, McMahon C, Gilman MSA, Clements JR, Clark S, Nguyen KM, Ho MH, Hu VJ, Shin JE, Feldman J, Hauser BM, Caradonna TM, Wingler LM, Schmidt AG, Marks DS, ... Abraham J, et al. Rapid generation of potent antibodies by autonomous hypermutation in yeast. Nature Chemical Biology. PMID 34168368 DOI: 10.1038/s41589-021-00832-4 |
0.537 |
|
2021 |
Ferrero S, Flores MD, Short C, Vazquez CA, Clark LE, Ziegenbein J, Zink S, Fuentes D, Payes C, Batto MV, Collazo M, García CC, Abraham J, Cordo SM, Rodriguez JA, et al. Antibody-based inhibition of pathogenic New World Hemorrhagic Fever mammarenaviruses by steric occlusion of the human transferrin receptor 1 apical domain. Journal of Virology. JVI0186820. PMID 34132574 DOI: 10.1128/JVI.01868-20 |
0.392 |
|
2021 |
Clark SA, Clark LE, Pan J, Coscia A, McKay LGA, Shankar S, Johnson RI, Brusic V, Choudhary MC, Regan J, Li JZ, Griffiths A, Abraham J. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell. PMID 33831372 DOI: 10.1016/j.cell.2021.03.027 |
0.349 |
|
2021 |
Koma T, Huang C, Coscia A, Hallam S, Manning JT, Maruyama J, Walker AG, Miller M, Smith JN, Patterson M, Abraham J, Paessler S. Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity. Plos Pathogens. 17: e1009356. PMID 33647064 DOI: 10.1371/journal.ppat.1009356 |
0.316 |
|
2020 |
Wellner A, McMahon C, Gilman MSA, Clements JR, Clark S, Nguyen KM, Ho MH, Shin JE, Feldman J, Hauser BM, Caradonna TM, Wingler LM, Schmidt AG, Marks DS, Abraham J, et al. Rapid generation of potent antibodies by autonomous hypermutation in yeast. Biorxiv : the Preprint Server For Biology. PMID 33200136 DOI: 10.1101/2020.11.11.378778 |
0.537 |
|
2020 |
Clark SA, Clark LE, Pan J, Coscia A, McKay LGA, Shankar S, Johnson RI, Griffiths A, Abraham J. Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 33200128 DOI: 10.1101/2020.11.13.381533 |
0.378 |
|
2020 |
Abraham J. Passive antibody therapy in COVID-19. Nature Reviews. Immunology. PMID 32533109 DOI: 10.1038/S41577-020-0365-7 |
0.359 |
|
2018 |
Clark LE, Mahmutovic S, Raymond DD, Dilanyan T, Koma T, Manning JT, Shankar S, Levis SC, Briggiler AM, Enria DA, Wucherpfennig KW, Paessler S, Abraham J. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses. Nature Communications. 9: 1884. PMID 29760382 DOI: 10.1038/S41467-018-04271-Z |
0.466 |
|
2018 |
Gruszczyk J, Kanjee U, Chan LJ, Menant S, Malleret B, Lim NTY, Schmidt CQ, Mok YF, Lin KM, Pearson RD, Rangel G, Smith BJ, Call MJ, Weekes MP, Griffin MDW, ... ... Abraham J, et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science (New York, N.Y.). 359: 48-55. PMID 29302006 DOI: 10.1126/Science.Aan1078 |
0.362 |
|
2015 |
Mahmutovic S, Clark L, Levis SC, Briggiler AM, Enria DA, Harrison SC, Abraham J. Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses. Cell Host & Microbe. 18: 705-713. PMID 26651946 DOI: 10.1016/J.Chom.2015.11.005 |
0.581 |
|
2013 |
Demogines A, Abraham J, Choe H, Farzan M, Sawyer SL. Dual host-virus arms races shape an essential housekeeping protein. Plos Biology. 11: e1001571. PMID 23723737 DOI: 10.1371/Journal.Pbio.1001571 |
0.404 |
|
2012 |
Helguera G, Jemielity S, Abraham J, Cordo SM, Martinez MG, RodrÃguez JA, Bregni C, Wang JJ, Farzan M, Penichet ML, Candurra NA, Choe H. An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses. Journal of Virology. 86: 4024-8. PMID 22278244 DOI: 10.1128/Jvi.06397-11 |
0.459 |
|
2011 |
Choe H, Jemielity S, Abraham J, Radoshitzky SR, Farzan M. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Current Opinion in Microbiology. 14: 476-82. PMID 21807555 DOI: 10.1016/J.Mib.2011.07.014 |
0.421 |
|
2010 |
Abraham J, Corbett KD, Farzan M, Choe H, Harrison SC. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nature Structural & Molecular Biology. 17: 438-44. PMID 20208545 DOI: 10.1038/Nsmb.1772 |
0.577 |
|
2010 |
Hood CL, Abraham J, Boyington JC, Leung K, Kwong PD, Nabel GJ. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. Journal of Virology. 84: 2972-82. PMID 20053739 DOI: 10.1128/Jvi.02151-09 |
0.408 |
|
2009 |
Abraham J, Kwong JA, Albariño CG, Lu JG, Radoshitzky SR, Salazar-Bravo J, Farzan M, Spiropoulou CF, Choe H. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. Plos Pathogens. 5: e1000358. PMID 19343214 DOI: 10.1371/Journal.Ppat.1000358 |
0.421 |
|
2007 |
Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature. 446: 92-6. PMID 17287727 DOI: 10.1038/Nature05539 |
0.444 |
|
Show low-probability matches. |